Refund Claims For Cancer-Fighting Drug Taxol
In April 2003, the Pennsylvania Office of Attorney General, along with 49 other state attorneys general, entered into a settlement with Bristol Myers-Squibb to resolve claims that Bristol Myers-Squibb manipulated the federal patent process to extend its monopoly on its cancer-fighting drug Taxol.
Taxol, and its generic version Paclitaxel, is used to treat non-small cell lung cancer, breast and ovarian cancers and AIDS-related Kaposi's sarcoma. Persons treated with Taxol or Paclitaxel from January 1, 1999 through February 28, 2003 or the legal representative of a deceased cancer patient who paid for all or part of Taxol or Paclitaxel treatments during this time are eligible to file claims.
A claim form may be obtained by visiting www.taxolsettlement.com or calling 1-800-659-7609. Claims must be submitted by February 29, 2004.